11:42 AM EST - Nuvo Research Inc. : Announced that the United States Patent and Trademark Office has granted a new U.S. patent number 9,084,754 ('754 Patent). The '754 Patent claims cover highly permeating topical formulations of terbinafine, an antifungal drug, and methods for treating onychomycosis. Nuvo Research Inc.
shares T.NRI are trading down $0.12 at $5.30.
